Sesen Bio Names Dennis Kim Chief Medical Officer

Xconomy Boston — 

Dennis Kim has joined Sesen Bio (NASDAQ: SESN) as the Cambridge, MA, biotech’s chief medical officer. Kim’s experience includes posts at Ipsen, Spectrum Pharmaceuticals, Novartis (NYSE: NVS), and Amgen (NASDAQ: AMGN). Sesen was originally founded as Eleven Biotherapeutics. The company’s most advanced drug candidate, VB4-845, is in late-stage studies testing it as a treatment for bladder cancer.